SCHEMBL6971665

SCHEMBL6971665

Cc1cc(CO)ccc1S(=O)(=O)Nc1ccc(F)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.54
LMNA P02545 3/20 0.54
PKM P14618 3/20 0.52
TAS2R14 Q9NYV8 1/20 0.52
NPSR1 Q6W5P4 2/20 0.51
HPGD P15428 1/20 0.51
ALDH1A1 P00352 3/20 0.49
MAPT P10636 2/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
CYP1A2 P05177 1/20 0.49
GLA P06280 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
RECQL P46063 1/20 0.49
IDH1 O75874 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976424 0.87 LMNA (0.55) HTTLMNAPKMTAS2R14NPSR1
SCHEMBL16528853 0.82 ALDH1A1 (0.54) HPGDALDH1A1MAPTKMT2AMEN1
SCHEMBL16469809 0.80 SIRT6 (0.46) HPGDALDH1A1MAPTKMT2AMEN1
SCHEMBL6980613 0.76 FFAR1 (0.64) LMNAPKMALDH1A1MAPTKMT2A
SCHEMBL6974155 0.76 LMNA (0.55) HTTLMNAPKMTAS2R14NPSR1
SCHEMBL6983341 0.75 METAP2 (0.56) HTTLMNAMAPTKMT2AMEN1
SCHEMBL842705 0.72 L3MBTL1 (0.53) LMNAALDH1A1
SCHEMBL1802409 0.72 ESR2 (0.41) LMNAHPGDALDH1A1RECQLBRD4
SCHEMBL4815825 0.71 HDAC3 (0.69) PKMATM
SCHEMBL11891711 0.71 AKT1 (0.50) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed